Remove 2024 Remove Assay Development Remove Drug Development
article thumbnail

High-performance microplates for discovery sciences

Drug Discovery World

This paid-for advertorial by Aurora Microplates appeared in DDW Volume 25 – Issue 1, Winter 2023/2024 Aurora Microplates is 100% focused on making the highest quality, highest performing microplates available.

Science 130
article thumbnail

How improved assay analysis benefits early drug discovery

Drug Discovery World

RA: What advantages can better analysis into assays bring to drug developers? AW : Better analysis into assays offers a multitude of advantages, including an enhanced understanding of compound activity and early identification of promising candidates.

Drugs 147
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Advances in cell line development

Drug Discovery World

Reece Armstrong offers an overview of cell line development and outlines the benefits the technology is bringing to biopharmaceutical developers. Cell line development is an essential underpinning of the drug development process, enabling teams to test, optimise and manufacture therapeutics at a commercial scale.

Vaccine 147
article thumbnail

AI At The Frontier: Empowering Early Career Professionals In Drug Discovery

Elrig

My role involved generating and characterizing complex proteins critical for biological assay development, hit discovery, and structural biology. This involved designing and implementing biological strategies, encompassing target validation, hit identification, establishing assays, and collaborating on structural work.

article thumbnail

Article EMA Thank You EMA finalizes clinical anticancer therapeutic guidance update

Agency IQ

The revisions flesh out considerations for use of biomarkers at all stages of product development and add new content on rare cancers and platform trial designs. BY KIRSTEN MESSMER, PHD, RAC, KARI OAKES | JAN 31, 2024 9:01 PM CST Regulatory Background Cancer is the second leading cause of death in the E.U. were from cancer.